FDA Approves Levocetirizine Dihydrochloride for Paediatric Nasal Allergies
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




FDA Approves Levocetirizine Dihydrochloride for Paediatric Nasal Allergies

NEW YORK -- August 25, 2009 -- The US Food and Drug Administration (FDA) has approved levocetirizine dihydrochloride (Xyzal) for children aged 6 months and older for the relief of symptoms of perennial allergic rhinitis and chronic idiopathic urticaria, and for children aged 2 years and older for symptoms of seasonal allergic rhinitis.

"There are options for treating nasal allergies in young children, one of which is [levocetirizine dihydrochloride]," said Michael Blaiss, MD, Department of Pediatrics and Medicine, University of Tennessee Health Science Center, Memphis Tenessee.

"The availability of a liquid treatment with the established safety and efficacy of levocetirizine dihydrochloride provides caregivers a new treatment option that can help relieve nasal allergy symptoms in young patients once diagnosed by a physician."

In patients aged 12 years and older, side effects may include sleepiness, tiredness, sore throat, and dry mouth. In children aged 6 to 12 years, side effects may include fever, cough, sleepiness, and nose bleeds. In children aged 1 to 5 years, side effects may include fever, diarrhoea, vomiting, and ear infections. In children aged 6 months to 11 months, side effects may include diarrhea and constipation.

SOURCE: UCB and Sanofi-Aventis

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities